{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:53:57Z","timestamp":1777366437585,"version":"3.51.4"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"abstract":"<jats:p>Objective. Matrix metalloproteinases (MMPs) and the angiogenic proteins basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) have been implicated in mechanisms of human cancer and metastasis. Assays were conducted on the urine of patients with vascular anomalies (tumors and malformations), relatively common and occasionally life-threatening disorders for which few therapies exist. We sought to determine whether these angiogenesis modulators are present in the urine and whether their expression is associated with the extent and clinical course of the vascular lesion.<\/jats:p>\n               <jats:p>Methods. A total of 217 patients with vascular anomalies and 74 age-matched control subjects participated. Urinary MMP expression was determined by substrate gel electrophoresis. Urinary bFGF and VEGF levels were measured by enzyme-linked immunosorbent assay. Each patient was assigned to 1 of 2 categories (tumor or malformation) and 1 of 9 specific groups. Extent of the vascular lesion and activity were scored by a blinded clinician.<\/jats:p>\n               <jats:p>Results. Urinary high molecular weight (hMW) MMPs and bFGF were significantly increased in patients with vascular tumors (53%) and vascular malformations (41%), compared with control subjects (22%). These percentages increased as a function of extent of the lesion and disease activity. hMW MMPs were increased in 4 groups: infantile hemangioma, other vascular neoplasms, lymphatic malformation and capillary-lymphaticovenous malformations, and extensive and unremitting capillary malformation and arteriovenous malformation. No significant differences among the groups were detected for low molecular weight MMPs or VEGF.<\/jats:p>\n               <jats:p>Conclusions. Expression patterns of hMW MMPs and bFGF in the urine of patients with tumors and malformations are consistent with their different clinical behavior. These data represent the first evidence that MMPs are elevated in the urine of children with vascular anomalies. These data also suggest that the increased expression of urinary MMPs parallels the extent and activity of vascular anomalies in children. In addition to tumors, vascular malformations are angiogenesis dependent, suggesting that progression of a vascular malformation might be suppressed by angiogenic inhibitors, which would target bFGF and MMPs.<\/jats:p>","DOI":"10.1542\/peds.2004-1518","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T18:17:49Z","timestamp":1120241869000},"page":"38-45","source":"Crossref","is-referenced-by-count":87,"title":["Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies"],"prefix":"10.1542","volume":"116","author":[{"given":"Jennifer J.","family":"Marler","sequence":"first","affiliation":[{"name":"Vascular Anomalies Center and Departments of"},{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Fishman","sequence":"additional","affiliation":[{"name":"Vascular Anomalies Center and Departments of"},{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Kilroy","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Fang","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Upton","sequence":"additional","affiliation":[{"name":"Vascular Anomalies Center and Departments of"},{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Mulliken","sequence":"additional","affiliation":[{"name":"Vascular Anomalies Center and Departments of"},{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E.","family":"Burrows","sequence":"additional","affiliation":[{"name":"Vascular Anomalies Center and Departments of"},{"name":"Radiology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judah","family":"Folkman","sequence":"additional","affiliation":[{"name":"Vascular Anomalies Center and Departments of"},{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha A.","family":"Moses","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,7,1]]},"reference":[{"key":"2021120905531643300_R1","unstructured":"Mulliken J, Young A. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, PA: WB Saunders; 1988:35\u201364"},{"key":"2021120905531643300_R2","doi-asserted-by":"crossref","unstructured":"Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg.\u20081982;69:412\u2013422","DOI":"10.1097\/00006534-198203000-00003"},{"key":"2021120905531643300_R3","doi-asserted-by":"crossref","unstructured":"Mulliken JB. A biologic approach to cutaneous vascular anomalies. Pediatr Dermatol.\u20081992;9:356\u2013357","DOI":"10.1111\/j.1525-1470.1992.tb00629.x"},{"key":"2021120905531643300_R4","unstructured":"Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery.\u20081982;92:348\u2013353"},{"key":"2021120905531643300_R5","doi-asserted-by":"crossref","unstructured":"Burrows PE, Mulliken JB, Fellows KE, et al. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol.\u20081983;141:483\u2013488","DOI":"10.2214\/ajr.141.3.483"},{"key":"2021120905531643300_R6","doi-asserted-by":"crossref","unstructured":"Burrows PE, Laor T, Paltiel H, et al. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin.\u20081998;16:455\u2013488","DOI":"10.1016\/S0733-8635(05)70246-1"},{"key":"2021120905531643300_R7","doi-asserted-by":"crossref","unstructured":"Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest.\u20081994;93:2357\u20132364","DOI":"10.1172\/JCI117241"},{"key":"2021120905531643300_R8","doi-asserted-by":"crossref","unstructured":"North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol.\u20082000;31:11\u201322","DOI":"10.1016\/S0046-8177(00)80192-6"},{"key":"2021120905531643300_R9","doi-asserted-by":"crossref","unstructured":"Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg.\u20081972;175:409\u2013416","DOI":"10.1097\/00000658-197203000-00014"},{"key":"2021120905531643300_R10","doi-asserted-by":"crossref","unstructured":"Folkman J. What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst.\u20081990;82:4\u20136","DOI":"10.1093\/jnci\/82.1.4"},{"key":"2021120905531643300_R11","doi-asserted-by":"crossref","unstructured":"Folkman J. Angiogenesis-dependent diseases. Semin Oncol.\u20082001;28:536\u2013542","DOI":"10.1053\/sonc.2001.29543"},{"key":"2021120905531643300_R12","doi-asserted-by":"crossref","unstructured":"Fujimoto K, Ichimori Y, Kakizoe T, et al. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun.\u20081991;180:386\u2013392","DOI":"10.1016\/S0006-291X(05)81305-1"},{"key":"2021120905531643300_R13","unstructured":"Garbisa S, Scagliotti G, Masiero L, et al. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res.\u20081992;52:4548\u20134549"},{"key":"2021120905531643300_R14","doi-asserted-by":"crossref","unstructured":"Baker T, Tickle S, Wasan H, et al. Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer.\u20081994;70:506\u2013512","DOI":"10.1038\/bjc.1994.336"},{"key":"2021120905531643300_R15","doi-asserted-by":"crossref","unstructured":"Fujimoto K, Ichimori Y, Yamaguchi H, et al. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn J Cancer Res.\u20081995;86:182\u2013186","DOI":"10.1111\/j.1349-7006.1995.tb03037.x"},{"key":"2021120905531643300_R16","doi-asserted-by":"crossref","unstructured":"Gohji K, Fujimoto N, Komiyama T, et al. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer.\u20081996;78:2379\u20132387","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2379::AID-CNCR17>3.0.CO;2-Y"},{"key":"2021120905531643300_R17","doi-asserted-by":"crossref","unstructured":"Gohji K, Fujimoto N, Hara I, et al. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer.\u20081998;79:96\u2013101","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F"},{"key":"2021120905531643300_R18","unstructured":"Schmalfeldt B, Prechtel D, Harting K, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res.\u20082001;7:2396\u20132404"},{"key":"2021120905531643300_R19","unstructured":"Moses MA, Wiederschain D, Loughlin KR, et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res.\u20081998;58:1395\u20131399"},{"key":"2021120905531643300_R20","doi-asserted-by":"crossref","unstructured":"Nguyen M, Watanabe H, Budson AE, et al. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst.\u20081993;85:241\u2013242","DOI":"10.1093\/jnci\/85.3.241"},{"key":"2021120905531643300_R21","doi-asserted-by":"crossref","unstructured":"Nguyen M, Watanabe H, Budson AE, et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst.\u20081994;86:356\u2013361","DOI":"10.1093\/jnci\/86.5.356"},{"key":"2021120905531643300_R22","doi-asserted-by":"crossref","unstructured":"Landriscina M, Cassano A, Ratto C, et al. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer.\u20081998;78:765\u2013770","DOI":"10.1038\/bjc.1998.575"},{"key":"2021120905531643300_R23","doi-asserted-by":"crossref","unstructured":"Braunhut SJ, Moses MA. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J Biol Chem.\u20081994;269:13472\u201313479","DOI":"10.1016\/S0021-9258(17)36856-4"},{"key":"2021120905531643300_R24","doi-asserted-by":"crossref","unstructured":"Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL): modulation of MMP-9 activity by NGAL. J Biol Chem.\u20082001;276:37258\u201337265","DOI":"10.1074\/jbc.M106089200"},{"key":"2021120905531643300_R25","doi-asserted-by":"crossref","unstructured":"Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4th ed. Oxford, England: Blackwell Science; 2002:277\u2013289","DOI":"10.1002\/9780470773666"},{"key":"2021120905531643300_R26","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley & Sons; 2000: 48\u201374","DOI":"10.1002\/0471722146"},{"key":"2021120905531643300_R27","doi-asserted-by":"crossref","unstructured":"Thrailkill KM, Kumar S, Rosenberg CK, et al. Characterization of matrix metalloproteinases in human urine: alterations during adolescence. Pediatr Nephrol.\u20081999;13:223\u2013229","DOI":"10.1007\/s004670050597"},{"key":"2021120905531643300_R28","doi-asserted-by":"crossref","unstructured":"Hashimoto T, Wen G, Lawton MT, et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke.\u20082003;34:925\u2013931","DOI":"10.1161\/01.STR.0000061888.71524.DF"},{"key":"2021120905531643300_R29","doi-asserted-by":"crossref","unstructured":"Ginns LC, Roberets DH, Mark EJ, et al. Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline. Chest.\u20082003;124:2017\u20132022","DOI":"10.1378\/chest.124.5.2017"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/1\/38\/1033531\/zpe00705000038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/1\/38\/1033531\/zpe00705000038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:49:29Z","timestamp":1639093769000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/1\/38\/72925\/Increased-Expression-of-Urinary-Matrix"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,7,1]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1518","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}